Cargando…
Abstract 28: Change in glycaemic parameters in adults with type 2 diabetes initiated with or switched to insulin degludec/insulin aspart (IDegAsp) in a real-world setting – An analysis of Indian cohort of ARISE study
Aim: To investigate the effect of insulin degludec/insulin aspart (IDegAsp) on glycaemic control in people with T2DM treated with IDegAsp in real-world setting. Methods: This was a ~26 weeks open-label, non-interventional study (NCT04042441) including 1102 T2DM adults on any anti-hyperglycaemic trea...
Autores principales: | Baruah, Manash P, Aneja, Pankaj, Pitale, Shailesh, Bhograj, Abhijit, Agrawala, Ritesh K, Aggarwal, Ajay, Mahadev, Prasad Gurumallappa, Madhavdas, Deepaklal Chhabrai, Shah, Sanjay, Pathan, Muzammil Khan A, Praveen, A N, Manjunatha, R, Singh, Kiran Pal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067817/ http://dx.doi.org/10.4103/2230-8210.342142 |
Ejemplares similares
-
Efficacy and Safety of Insulin Degludec/Insulin Aspart (IDegAsp) in Type 2 Diabetes: Systematic Review and Meta-Analysis
por: Edina, Brenda C, et al.
Publicado: (2022) -
Distinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes Mellitus
por: Heise, Tim, et al.
Publicado: (2014) -
In-hospital experience with insulin degludec (IDeg)
por: Bulisani, Maria Gabriela Pedigoni, et al.
Publicado: (2015) -
Abstract 21: The burden of mealtime insulin dosing in adults and children with type 1 diabetes
por: Revanna, Manjunatha, et al.
Publicado: (2022) -
Abstract 5: Similar hypoglycemia duration with once-weekly insulin icodec versus insulin glargine U100 in insulin naïve or experienced patients with T2D
por: Manjunath, Aparna, et al.
Publicado: (2022)